Saik Andrew

CIK 00016162846 companiesNEW HAVEN, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001616284

Recent Transactions

50 trades

Award
ARVINAS, INC.$ARVN
Stock Option (right to buy)
2026-02-26+67,000→ 67,000 total
Award
ARVINAS, INC.$ARVN
Common Stock
2026-02-26+45,000→ 204,267 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2026-02-13$11.89/sh−5,134→ 159,267 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2025-06-24$7.61/sh−5,700→ 164,401 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2025-06-10+40,000→ 40,000 total
Award
ARVINAS, INC.$ARVN
Stock Option (right to buy)
2025-05-09+91,000→ 91,000 total
Award
ARVINAS, INC.$ARVN
Common Stock
2025-05-09+59,600→ 170,101 total
Award
ARVINAS, INC.$ARVN
Stock Option (right to buy)
2025-02-13+74,960→ 74,960 total
Award
ARVINAS, INC.$ARVN
Common Stock
2025-02-13+49,092→ 110,501 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2024-08-28+40,000→ 40,000 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2024-07-15−80,000→ 80,000 total
Award
ARVINAS, INC.$ARVN
Stock Option (right to buy)
2024-06-24+94,418→ 94,418 total
Award
ARVINAS, INC.$ARVN
Common Stock
2024-06-24+61,409→ 61,409 total
Disposition from Tender
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−23,021→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−17,600→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−72,540→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−45,244→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−24,000→ 0 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-09-21$10.80/sh−908→ 68,265 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-06-21$11.74/sh−908→ 69,173 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-03-21$14.19/sh−909→ 70,081 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-01-27+14,700→ 70,990 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-01-27+24,000→ 24,000 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2022-12-31$12.37/sh−718→ 56,290 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2022-12-21$13.43/sh−908→ 57,008 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2022-09-21$14.85/sh−908→ 57,916 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2022-06-21$12.48/sh−3,632→ 58,824 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2022-01-27+17,600→ 17,600 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2022-01-27+10,300→ 62,456 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2021-06-21+72,540→ 72,540 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-06-21+52,156→ 52,156 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2021-05-28$3.36/sh+3,017→ 116,468 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2021-03-31$6.84/sh−762→ 113,451 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2021-02-22+68,162→ 68,162 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2021-02-22+29,213→ 114,213 total
Purchase
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-09-08$1.46/sh+40,000→ 340,000 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2020-05-06+250,000→ 250,000 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-05-06+250,000→ 300,000 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2020-03-23+100,000→ 100,000 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-03-23+50,000→ 50,000 total
Award
PDS Biotechnology Corp$PDSB
Common Stock
2020-02-14$1.30/sh+38,400→ 42,549 total
Award
PDS Biotechnology Corp$PDSB
Stock Option (Right To Purchase)
2019-06-06+62,715→ 62,715 total
Exercise/Conversion
PDS Biotechnology Corp$PDSB
Restricted Stock Units
2019-03-15−82,999→ 0 total
Exercise/Conversion
PDS Biotechnology Corp$PDSB
Common Stock
2019-03-15+82,999→ 82,999 total
Award
PDS Biotechnology Corp$PDSB
Restricted Stock Units
2018-08-14+82,999→ 82,999 total
Award
PDS Biotechnology Corp$PDSB
Stock Option (Right To Purchase)
2018-06-19+166,001→ 166,001 total
Award
PDS Biotechnology Corp$PDSB
Stock Option (Right To Purchase)
2018-03-01+50,000→ 50,000 total
Award
PDS Biotechnology Corp$PDSB
Stock Option (Right To Purchase)
2017-11-01+200,000→ 200,000 total
Other
AUXILIUM PHARMACEUTICALS INC
Nonqualified Employee Stock Option (Right to Buy)
2015-01-29$36.53/sh−165,000→ 0 total
Other
AUXILIUM PHARMACEUTICALS INC
Common Stock
2015-01-29$36.53/sh−10,000→ 0 total

Companies

Recent Filings

Address

C/O ARVINAS, INC. 5 SCIENCE PARK, 395 WINCHESTER AVE.

NEW HAVEN, CT, 06511

View on SEC.gov